「the clinical」の検索結果
88件：81～85件目を表示
もしかして
-
treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 ant...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
tical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osak...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 ant...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
tical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osak...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
Research and Development System | Research & Development | SENJU Pharmaceutica
through a flexible concept without adhering to a conventional framework or stereotypes. Looking at the future and quickly developing safe drugs that are needed are our goals as well as our wishes. Me...
http://www.senju.co.jp/english/rd/about/